News - Page 171 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Horizons ETFs Rebalances World’s First Psychedelics ETF

Horizons ETFs Rebalances World’s First Psychedelics ETF

Post published:July 6, 2021
Post category:Press Release

Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology

Post published:July 6, 2021
Post category:Press Release

Read more about the article Psyched Wellness Receives Positive Results from Its 14-Day Oral Toxicity Preclinical Study

Psyched Wellness Receives Positive Results from Its 14-Day Oral Toxicity Preclinical Study

Post published:July 6, 2021
Post category:Press Release

Read more about the article Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence

Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence

Post published:July 6, 2021
Post category:Press Release

Read more about the article COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK

COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK

Post published:July 5, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Harvard Law School Launches Psychedelics Project; California Decrim. Bill Clears Latest Hurdle; LSD for Food Allergies?

Psychedelic Bulletin: Harvard Law School Launches Psychedelics Project; California Decrim. Bill Clears Latest Hurdle; LSD for Food Allergies?

Post published:July 2, 2021
Post category:Psychedelic Bulletin

Read more about the article Psilera Raises $2.5 Million with Oversubscribed Series Seed from Leading Institutional Investors to Accelerate Clinical Pipeline Focused on DMT

Psilera Raises $2.5 Million with Oversubscribed Series Seed from Leading Institutional Investors to Accelerate Clinical Pipeline Focused on DMT

Post published:July 1, 2021
Post category:Press Release

Read more about the article Harvard Law School’s Petrie-Flom Center Launches Research Initiative on Psychedelics and the Law

Harvard Law School’s Petrie-Flom Center Launches Research Initiative on Psychedelics and the Law

Post published:June 30, 2021
Post category:Analysis News

Read more about the article Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding Consultant

Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding Consultant

Post published:June 30, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana

Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana

Post published:June 30, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.